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Elective surgery for colorectal cancer in the aged:
a clinical-economical evaluation
RA Audisio*, M Cazzaniga, C Robertson, P Veronesi, B Andreoni and MS Aapro*
EIO - European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy
Summary A series of 56 consecutive patients, referred for surgery to a specialized institute, had elective laparotomies with various surgical
procedures aimed at curing locoregional colorectal cancer. Data defining patient and tumour-related preoperative, operative and post-
operative variables, including costs, were collected. The study group was divided into two age groups (<65 vs.65 years), which were similar
in terms of patient- and tumour-related variables. Differences were not statistically significant (£440; 95% exact Cl; £ -50; 1800). There is no
evidence to suggest that there are any total charge differences in treating the two age groups, as confirmed by the cost analysis.
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Almost 50% of deaths from colorectal cancer occur in patients
over 75 years ofage (Silverberg et al, 1990) and the median age at
diagnosis is around 68.4 years for rectal and 70.5 years for colon
cancer (Young et al, 1981), the incidence ofcolorectal malignancy
increasing steadily up to the eight decade (Winawer et al, 1984). A
difference in the clinical presentation is being reported (Arnaud et
al, 1991) as a consequence of a twofold increase in right-sided
cancers, which are responsible for occult bleeding, occlusion and
nutritional impairment. Obstructing tumours are significantly
more common in patients over 70 years of age (Korenaga et al,
1991), requiring emergency operation; this is associated with a
significantly higher incidence of operative deaths at any age
(Turunen et al, 1983; Irvin, 1988), but the prevalence ofoperative
morbidity and mortality among the aged on emergency is signifi-
cantly higher than for younger patients under the same conditions,
in both eastern and western series (Korenaga et al, 1991; Mulcahy
et al, 1994). When only elective operations are considered, any
difference in operative deaths recorded in the two age groups is
small, ranging from 4% to 7% (Arnaud et al, 1991; Mulcahy et al,
1994). Kingston et al (1995) recorded a significant increase in the
length of hospital stay in the over 75 age group (16 vs 13 days),
although post-operative wound infection and leak rates were not
significantly different: this was explained by a more detailed time-
consuming preoperative evaluation. Finally, survival is better for
younger patients, but this difference loses statistical significance
when survival curves plotted for patients undergoing potentially
curative surgery and malignant deaths are considered (Mulcahy et
al, 1994). This stimulated ourinterest in assessing the difference in
the economical burden when delivering radical surgery to the aged
colorectal cancer patient vs younger ones, in order to address a
common clinical problem. The advantage ofdoing such a study at
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the EIO, Milan, is that we can provide all information about costs
in aEuropean setting. In these times ofhealth economic evaluation
and ofhospital purchasing, it is essential to know whether the allo-
cation of the financial resources is equitable. A higher cost of
treatment in the elderly compared with the young with the same
disease could implicate, if budgetary reasons prevail, an ethical
problem as some could take cost as a reason not to treat.
PATIENTS AND METHODS
The consecutive series of56 stage I-III colorectal cancer subjects,
all of whom were surgically treated for cure at the European
Institute ofOncology, Milan, from its opening in May 1994 to June
1996, are entered into the present study. There is no selection bias
of patients once they have been referred to this institute. Several
variables were collected, including patient- and tumour-related
ones (Table 1), perioperative data (Table 2) and costs (Table 3).
Costs are expressed in pounds sterling and define (a) preoperative
real costs, which include diagnostic and staging packages, tests and
investigations used to assess operability as well as specific cardio-
logic investigations when required; (b) operative real costs which
include computing, surgical and anaesthesiological equipment but
exclude the costs of the staff; (c) post-operative real costs, which
include the real costs ofdaily hospital or ICU stay times numberof
days ofadmittance, drugs andbloodunits delivered to each patient,
post-operative tests and investigations, reinterventions and the staff
real cost, defined as the daily salary of each staff member multi-
plied by the number of days spent in the unit; and (d) total charge
to the patient from a private non-profit Italian institution, as the
EIO is, representing the bill the patient is asked to pay when
leaving the hospital. A cut-off point of 65 years was used to
dichotomize the series into two age groups to be compared. The
differences in median costs between the two groups were tested
according to the Wilcoxon rank sum test and confidence intervals
provided by the Hodges-Lehmann estimate; Fisher's exact test
was used for testing equality ofproportions.
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Table 2 Operative variables
<65 years .65 years
Median operation hours 3.75 3.0
Range 1.5-6.5 2.0-5.0
Median number blood units 0 0
Range 0-5.0 0-47.0
Median ICU stay (days) 0 0
Range 0-3 0-65








Table 3 Costs and charges in sterling
<65 years .65 years
Preoperative investigations 400 400
Range 400-480 400-520
Operative real costs" 1040 1040
Range 880-1040 800-1040
Post-operative realcostsb 6280 6680
Range 4440-32040 5040-23260
Median total charges 7720 8160
Range 5880-33480 6480-24540
aStaff excluded; bStaff included.
RESULTS
The patients entered into the study represent all those referred for
surgery to our centre. The two groups were similar in terms ofclin-
icopathological variables (Table 1). A slight increased prevalence
of right-sided colon cancers was detected among patients
2 65 years, which was responsible for 20% of right colectomies
vs 3.8% in the younger age group, (P = 0.11).
The overall length of the operation ranged from 1 h 30 min to
6 h 30 min, with a median time of 3 h 30 min (Table 2). Special
care in avoiding uncontrolled bleeding is our policy, and most
patients had no transfusion at all; five patients aged < 65 required
homologous blood, compared with nine patients in the 2 65 years
age group. Patients were sent to the ICU on the basis of a multi-
parametric scoring system that took account of preoperative
assessment, length of operation and blood loss, number of blood
units replaced and peroperative surgical and anaesthesiological
complications. Median ICU stay was 0 days for both age groups,
but 6 out of 20 patients <65 had more than 1 day in the ICU vs 12
out of 30 among the .65-year-old group. The difference in opera-
tive (30 days) morbidity was statistically not significant, and none
of the groups showed any post-operative mortality.
When costs are analysed (Table 3), the preoperative investiga-
tional package is standardized for all colorectal cancer patients, no
matter the age group; thus minor variations are to be ascribed to
Holter monitoring and pulmonary function testing occasionally
performed in the elderly at the cardiologist's request. Operative
real costs are equivalent in both groups because of the use of a
standard operative technique, and consequently there are similar
expenses for the operative equipment. A moderate, but not statisti-
cally significant (P = 0.07), increase in post-operative real costs
for the .65 years old subjects (the median is £400 greater) is to be
ascribed to a more intensive post-operative monitoring. The
median total charge to the patient is also similar in both age
groups. There is no evidence to suggest that there are major differ-
ences in treating the two age groups, as confirmed by the cost
analysis. The difference in the median costs is £440, with a 95.2%
exact confidence interval for the differences in the total costs
between patients in the two groups of £ (-50; 1800). Similar
conclusions are reached if the study population is divided around
the median age of 69 years.
The median age at diagnosis for colon cancer is 69, and using
this as a cut-offpoint to give two groups, one with age less than or
equal to 69 and the other aged 70 or over, yielded similar results.
Specifically, the difference of the median costs is £400, with a
95.2% exact confidence interval for the differences in the total
costs between patients in the two groups of-£120 and£1750.
DISCUSSION
Surgery is the first choice treatment for colorectal cancer patients,
the most prevalent cancerous disease among elderly subjects: this
age group does not show an increased operative morbidity and
mortality when operated under elective conditions, and is almost
four times more frequently treated than in the 1940s (Lea et al,
1982). This study has addressed a group of patients referred to a
tertiary centre forelective surgery. The conclusion therefore cannot
apply to a non-selected population with severe co-morbidity.
Admittedly, if we consider the £400 median difference in cost
per patient and we multiply it by the number of elderly patients
treated in this institute, then the total cost could be £12 000 more
than if all patients were less than 65 years old compares with a
total budget of£500000 for treating 56 patients. This represents a
2-3% increase on the total budget. Even atthe mostextreme confi-
dence limit, the excess costs of treating elderly patients are less
than 10% of the total budget. These are small increments on a
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large sum of money, and it is a political decision to determine
how to allocate a country's budget: to the military, explorations,
tobacco subsidies, industry or health.
Financial issues intrude on medicine from all fronts, and cost
analysis ofcommon conditions is required to address clinical prac-
tice. A commonly proposed reason for not treating elderly patients
is that one should consider their active life expectancy (Katz et al,
1983), which obviously increases apparent cost in health economic
terms. This is a political decision that a physician should not have
to face (Sulmasy, 1992). It has been demonstrated that strategies to
improve the prognosis ofcolorectal cancer should not exclude the
older patients (Mulcahy et al, 1994), and our small prospective
series contributes to this conclusion.
This is a small series ofdata, butone thatdeals with an important
area. It is correct to conclude that one ofthe major sources of cost
difference between the two groups is likely to be serious adverse
events requiring expensive treatment. One would expect that this is
more likely to occurin the older group. In our study there were two
adverse events in each group, all ofwhich had very high costs.
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